Provided by Tiger Trade Technology Pte. Ltd.

Inovio Pharmaceuticals

1.58
-0.0700-4.24%
Post-market: 1.620.0352+2.23%19:55 EDT
Volume:993.94K
Turnover:1.59M
Market Cap:109.17M
PE:-0.87
High:1.67
Open:1.66
Low:1.58
Close:1.65
52wk High:2.98
52wk Low:1.30
Shares:69.09M
Float Shares:66.44M
Volume Ratio:1.32
T/O Rate:1.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8117
EPS(LYR):-1.8117
ROE:-183.47%
ROA:-57.88%
PB:4.53
PE(LYR):-0.87

Loading ...

Inovio Pharmaceuticals: Hold Rating Amid Financial Challenges and Pending Regulatory Milestones

TIPRANKS
·
Nov 17, 2025

Inovio Pharmaceuticals Inc. Stock Rises 5.1%, Outperforms Peers

Dow Jones
·
Nov 15, 2025

Inovio Pharma Price Target Raised to $6.00/Share From $5.00 by Piper Sandler

Dow Jones
·
Nov 15, 2025

U.S. RESEARCH ROUNDUP-Disney, Enanta Pharmaceuticals, Phillips 66

Reuters
·
Nov 14, 2025

Inovio Pharmaceuticals Inc : Piper Sandler Raises Target Price to $6 From $5

THOMSON REUTERS
·
Nov 14, 2025

Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Nov 13, 2025

Inovio Shares Sink After Pricing $25M Public Offering

Dow Jones
·
Nov 12, 2025

BUZZ-Inovio Pharma falls on $25 mln stock sale

Reuters
·
Nov 11, 2025

Inovio 13.16M share Spot Secondary priced at $1.90

TIPRANKS
·
Nov 11, 2025

Inovio Announces Pricing of $25 Million Public Offering

THOMSON REUTERS
·
Nov 11, 2025

Inovio Pharmaceuticals Inc - Prices Public Offering of 13,158,000 Shares at $1.90 Each

THOMSON REUTERS
·
Nov 11, 2025

Inovio announces common stock offering, no amount given

TIPRANKS
·
Nov 11, 2025

BRIEF-Inovio Announces Proposed Public Offering

Reuters
·
Nov 11, 2025

Inovio Pharmaceuticals Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
Nov 11, 2025

Inovio Q3 net loss widens on non-cash warrant liabilities

Reuters
·
Nov 11, 2025

Inovio Pharmaceuticals posts $21.2 million operating loss for Q3 2025

Reuters
·
Nov 11, 2025

BRIEF-Inovio Pharmaceuticals Q3 EPS USD -0.87

Reuters
·
Nov 11, 2025

Inovio Pharmaceuticals: Expect to Receive File Acceptance by Year End 2025 for Ino-3107

THOMSON REUTERS
·
Nov 11, 2025

Inovio Pharmaceuticals: Potential Pdufa Date in Mid-2026 IF Priority Review Request Granted for Ino-3107

THOMSON REUTERS
·
Nov 11, 2025

Inovio Pharmaceuticals Q3 EPS $(0.87) Misses $(0.42) Estimate

Benzinga
·
Nov 11, 2025